A Randomized, Open Label, Four-way Crossover Study to Compare the Pharmacokinetics of Mycophenolate Mofetil Metabolites From Four Tablet Formulations in Healthy Subjects
Latest Information Update: 16 Jan 2020
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Heart transplant rejection; Liver transplant rejection; Lung transplant rejection; Lupus nephritis; Pancreas transplant rejection; Renal transplant rejection; Transplant rejection
- Focus Pharmacokinetics
- Sponsors Roche
- 09 Aug 2019 Results published in the International Journal of Clinical Pharmacology and Therapeutics
- 07 Dec 2016 New trial record